Press Resease

Blood Glucose Monitoring System Market - Global Industry Analysis

Blood Glucose Monitoring System Market by Product (Self-Monitoring and Continuous Glucose Monitoring Devices), by Testing Site (Fingertip Testing and Alternate Site Testing), by Indication (Type-I Diabetes, Type-II Diabetes, and Others), and by End-User (Hospitals, Clinics, and Homecare): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Published Date: 17-Oct-2018 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-3435 Status : Published

Global blood glucose monitoring system market expected to generate around USD 18.87 billion in revenue by the end of 2024, growing at a CAGR of around 5.1% between 2018 and 2024. Blood glucose monitoring is a part of the standardized care for diabetes patients. It helps in monitoring and controlling the glucose level in diabetic individuals and impaired glucose tolerance.

Description

The report covers forecast and analysis for the blood glucose monitoring system market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the blood glucose monitoring system market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the blood glucose monitoring system market on a global level.

In order to give the users of this report a comprehensive view of the blood glucose monitoring system market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Blood Glucose Monitoring System Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type and regional expansion of major participants involved in the market.

The study provides a decisive view of the blood glucose monitoring system market by segmenting it based on product type, testing site, indications, end-user, and region. All the segments have been analyzed based on present and future trends and the market is forecasted from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and The Middle East & Africa. This segmentation includes demand for blood glucose monitoring system market based on all segments in all the regions and countries.

The key players in the global blood glucose monitoring system market are Abbott Laboratories, Novo Nordisk, Hoffmann-La Roche Ltd., Sanofi, Medtronic, Nova Biomedical, B. Braun Melsungen, Terumo Corporation, ARKRAY Inc., and Becton Dickinson.

This report segments the global blood glucose monitoring system market as follows:

Global Blood Glucose Monitoring System Market: Product Segment Analysis

  • Self-Monitoring
    • Blood Glucose Meters
    • Testing Strips
    • Lancets & Lancing Devices
  • Continuous Glucose Monitoring Devices

Global Blood Glucose Monitoring System Market: Testing Site Segment Analysis

  • Fingertip Testing
  • Alternate Site Testing

Global Blood Glucose Monitoring System Market: Indication Segment Analysis

  • Type-I Diabetes
    • Adult
    • Pediatrics
  • Type-II Diabetes
    • Adult
    • Pediatrics
  • Gestational Diabetes

Global Blood Glucose Monitoring System Market: End-User Segment Analysis

  • Hospitals
  • Clinics
  • Homecare

Global Blood Glucose Monitoring System Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global blood glucose monitoring system market, 2015 - 2024 (USD Billion)
    • 2.2. Global blood glucose monitoring system market: Snapshot
  •  
  • Chapter 3. Blood Glucose Monitoring System Market - Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global blood glucose monitoring system market drivers: Impact analysis
      • 3.2.2. Rising prevalence of diabetic population
      • 3.2.3. Increasing number of product launches
      • 3.2.4. Increasing preference for less invasive technologies
    • 3.3. Market Restraints
      • 3.3.1. Global blood glucose monitoring system market restraints: Impact analysis
      • 3.3.2. High cost of monitoring systems
      • 3.3.3. Inadequate reimbursement
    • 3.4. Opportunities
      • 3.4.1. Surge in online marketing strategies
      • 3.4.2. Technological advancement in products
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by testing site segment
      • 3.6.3. Market attractiveness analysis, by indication segment
      • 3.6.4. Market attractiveness analysis, by end user segment
      • 3.6.5. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Blood Glucose Monitoring System Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global blood glucose monitoring system market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New indication launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Blood Glucose Monitoring System Market -Product Segment Analysis
    • 5.1. Global blood glucose monitoring system market: Product overview
      • 5.1.1. Global blood glucose monitoring system market revenue share, by product, 2017 and 2024
    • 5.2. Self-Monitoring
      • 5.2.1. Global blood glucose monitoring system market for self-monitoring, 2015 - 2024 (USD Billion)
    • 5.3. Continuous Glucose Monitoring Devices
      • 5.3.1. Global blood glucose monitoring system market for continuous glucose monitoring devices, 2015 - 2024 (USD Billion)
  •  
  • Chapter 6. Global Blood Glucose Monitoring System Market -Testing Site Segment Analysis
    • 6.1. Global blood glucose monitoring system market: Mode of delivery overview
      • 6.1.1. Global blood glucose monitoring system market revenue share, by testing site, 2017 and 2024
    • 6.2. Fingertip Testing
      • 6.2.1. Global blood glucose monitoring system market for fingertip testing, 2015 - 2024 (USD Billion)
    • 6.3. Alternate Site Testing
      • 6.3.1. Global blood glucose monitoring system market for alternate site testing, 2015 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Blood Glucose Monitoring System Market -Indication Segment Analysis
    • 7.1. Global blood glucose monitoring system market: Indication overview
      • 7.1.1. Global blood glucose monitoring system market revenue share, by indication, 2017 and 2024
    • 7.2. Type-I Diabetes
      • 7.2.1. Global blood glucose monitoring system market for type-I diabetes, 2015 - 2024 (USD Billion)
    • 7.3. Type-II Diabetes
      • 7.3.1. Global blood glucose monitoring system market for type-II diabetes, 2015 - 2024 (USD Billion)
    • 7.4. Gestational Diabetes
      • 7.4.1. Global blood glucose monitoring system market for gestational diabetes, 2015 - 2024 (USD Billion)
  •  
  • Chapter 8. Global Blood Glucose Monitoring System Market - End-User Segment Analysis
    • 8.1. Global blood glucose monitoring system market: An End-user overview
      • 8.1.1. Global blood glucose monitoring system market revenue share, by end-user, 2017 and 2024
    • 8.2. Hospitals
      • 8.2.1. Global blood glucose monitoring system market for hospitals, 2015 - 2024 (USD Billion)
    • 8.3. Clinics
      • 8.3.1. Global blood glucose monitoring system market for clinics, 2015 - 2024 (USD Billion)
    • 8.4. Homecare
      • 8.4.1. Global blood glucose monitoring system market for homecare, 2015 - 2024 (USD Billion)
  •  
  • Chapter 9. Global Blood Glucose Monitoring System Market - Regional Segment Analysis
    • 9.1. Global blood glucose monitoring system market: Regional overview
      • 9.1.1. Global blood glucose monitoring system market revenue share, by region, 2017 and 2024
    • 9.2. North America
      • 9.2.1. North America blood glucose monitoring system market, 2015 - 2024 (USD Billion)
      • 9.2.2. North America blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
        • 9.2.2.1. North America blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
      • 9.2.3. North America blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
      • 9.2.4. North America blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.2.4.1. North America blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
        • 9.2.4.2. North America blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
      • 9.2.5. North America blood glucose monitoring system market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 9.2.6. The U.S.
        • 9.2.6.1. The U.S. blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.2.6.1.1. The U.S. blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.2.6.2. The U.S. blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.2.6.3. The U.S. blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.2.6.3.1. The U.S. blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.2.6.3.2. The U.S. blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.2.6.4. The U.S. blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.2.7. Canada
        • 9.2.7.1. Canada blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.2.7.1.1. Canada blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.2.7.2. Canada blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.2.7.3. Canada blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.2.7.3.1. Canada blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.2.7.3.2. Canada blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.2.7.4. Canada blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe blood glucose monitoring system market, 2015 - 2024 (USD Billion)
      • 9.3.2. Europe blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
        • 9.3.2.1. Europe blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
      • 9.3.3. Europe blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
      • 9.3.4. Europe blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.3.4.1. Europe blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
        • 9.3.4.2. Europe blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
      • 9.3.5. Europe blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.3.6. UK
        • 9.3.6.1. UK blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.3.6.1.1. UK blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.3.6.2. UK blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.3.6.3. UK blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.3.6.3.1. UK blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.3.6.3.2. UK blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.3.6.4. UK blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.3.7. Germany
        • 9.3.7.1. Germany blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.3.7.1.1. Germany blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.3.7.2. Germany blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.3.7.3. Germany blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.3.7.3.1. Germany blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.3.7.3.2. Germany blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.3.7.4. Germany blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.3.8. France
        • 9.3.8.1. France blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.3.8.1.1. France blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.3.8.2. France blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.3.8.3. France blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.3.8.3.1. France blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.3.8.3.2. France blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.3.8.4. France blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.3.9. Rest of Europe
        • 9.3.9.1. Rest of Europe blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.3.9.1.1. Rest of Europe blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.3.9.2. Rest of Europe blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.3.9.3. Rest of Europe blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.3.9.3.1. Rest of Europe blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.3.9.3.2. Rest of Europe blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.3.9.4. Rest of Europe blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific blood glucose monitoring system market, 2015 - 2024 (USD Billion)
      • 9.4.2. Asia Pacific blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
        • 9.4.2.1. Asia Pacific blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
      • 9.4.3. Asia Pacific blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
      • 9.4.4. Asia Pacific blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.4.4.1. Asia Pacific blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
        • 9.4.4.2. Asia Pacific blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
      • 9.4.5. Asia Pacific blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.4.6. China
        • 9.4.6.1. China blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.4.6.1.1. China blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.4.6.2. China blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.4.6.3. China blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.4.6.3.1. China blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.4.6.3.2. China blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.4.6.4. China blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.4.7. Japan
        • 9.4.7.1. Japan blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.4.7.1.1. Japan blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.4.7.2. Japan blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.4.7.3. Japan blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.4.7.3.1. Japan blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.4.7.3.2. Japan blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.4.7.4. Japan blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.4.8. India
        • 9.4.8.1. India blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.4.8.1.1. India blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.4.8.2. India blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.4.8.3. India blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.4.8.3.1. India blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.4.8.3.2. India blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.4.8.4. India blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.4.9.1.1. Rest of Asia Pacific blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.4.9.2. Rest of Asia Pacific blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.4.9.3. Rest of Asia Pacific blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.4.9.3.1. Rest of Asia Pacific blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.4.9.3.2. Rest of Asia Pacific blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.4.9.4. Rest of Asia Pacific blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America blood glucose monitoring system market, 2015 - 2024 (USD Billion)
      • 9.5.2. Latin America blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
        • 9.5.2.1. Latin America blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
      • 9.5.3. Latin America blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
      • 9.5.4. Latin America blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.5.4.1. Latin America blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
        • 9.5.4.2. Latin America blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
      • 9.5.5. Latin America blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.5.6.1.1. Brazil blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.5.6.2. Brazil blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.5.6.3. Brazil blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.5.6.3.1. Brazil blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.5.6.3.2. Brazil blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.5.6.4. Brazil blood glucose monitoring system market revenue, by end user, 2015 - 2024 (USD Billion)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
          • 9.5.7.1.1. Rest of Latin America blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
        • 9.5.7.2. Rest of Latin America blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
        • 9.5.7.3. Rest of Latin America blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
          • 9.5.7.3.1. Rest of Latin America blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
          • 9.5.7.3.2. Rest of Latin America blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
        • 9.5.7.4. Rest of Latin America blood glucose monitoring system market revenue, by end-user, 2015 - 2024 (USD Billion)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa blood glucose monitoring system market, 2015 - 2024 (USD Billion)
      • 9.6.2. The Middle East and Africa blood glucose monitoring system market revenue, by product, 2015 - 2024 (USD Billion)
        • 9.6.2.1. The Middle East and Africa blood glucose monitoring system market revenue, by self-monitoring, 2015 - 2024 (USD Billion)
      • 9.6.3. The Middle East and Africa blood glucose monitoring system market revenue, by testing site, 2015 - 2024 (USD Billion)
      • 9.6.4. The Middle East and Africa blood glucose monitoring system market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.6.4.1. The Middle East and Africa blood glucose monitoring system market revenue, by type-I diabetes, 2015 - 2024 (USD Billion)
        • 9.6.4.2. The Middle East and Africa blood glucose monitoring system market revenue, by type-II diabetes, 2015 - 2024 (USD Billion)
      • 9.6.5. The Middle East and Africa blood glucose monitoring system market revenue, by end-user, 2015 - 2024 (USD Billion)
  •  
  • Chapter 10. Company Profile
    • 10.1. Abbott Laboratories
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. Novo Nordisk A/S
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. Hoffmann-La Roche Ltd.
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. Sanofi
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. Medtronic
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Nova Biomedical
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. B. Braun Melsungen AG
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. Terumo Corporation
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments
    • 10.9. ARKRAY Inc.
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business Strategy
      • 10.9.5. Recent Developments
    • 10.10. Becton, Dickinson and Company
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business Strategy
      • 10.10.5. Recent Developments 

List of Figures
 
1. Market research process
2. Market research methodology
3. Global blood glucose monitoring system market revenue, 2015 – 2024 (USD Billion) 
4. Porter’s five forces analysis
5. Blood Glucose Monitoring System market attractiveness analysis, by product segment
6. Blood Glucose Monitoring System market attractiveness analysis, by testing site segment
7. Blood Glucose Monitoring System market attractiveness analysis, by indication segment
8. Blood Glucose Monitoring System market attractiveness analysis, by end user segment
9. Blood Glucose Monitoring System market: market attractiveness analysis, by regional segment
10. Company market share analysis, 2017 
11. Global blood glucose monitoring system market revenue share by product, 2017 and 2024
12. Global blood glucose monitoring system market for self-monitoring, 2015 – 2024 (USD Billion)
13. Global blood glucose monitoring system market for continuous glucose monitoring devices, 2015 – 2024 (USD Billion)
14. Global blood glucose monitoring system market revenue share by testing site, 2017 and 2024
15. Global blood glucose monitoring system market for fingertip testing, 2015 – 2024 (USD Billion)
16. Global blood glucose monitoring system market for alternate site testing, 2015 – 2024 (USD Billion)
17. Global blood glucose monitoring system market revenue share by indication, 2017 and 2024
18. Global blood glucose monitoring system market for type-I diabetes, 2015 – 2024 (USD Billion)
19. Global blood glucose monitoring system market for type-II diabetes, 2015 – 2024 (USD Billion)
20. Global blood glucose monitoring system market revenue share by end user, 2017 and 2024
21. Global blood glucose monitoring system market for hospitals, 2015 – 2024 (USD Billion)
22. Global blood glucose monitoring system market for cardiac centers, 2015 – 2024 (USD Billion)
23. North America blood glucose monitoring system market, 2015-2024 (USD Billion)
24. Europe blood glucose monitoring system market, 2015-2024 (USD Billion)
25. Asia Pacific blood glucose monitoring system market, 2015-2024 (USD Billion)
26. Latin America blood glucose monitoring system market, 2015-2024 (USD Billion)
27. The Middle East and Africa blood glucose monitoring system market, 2015-2024 (USD Billion)


List of Tables

1. Global blood glucose monitoring system market: Market Snapshot
2. Drivers of global blood glucose monitoring system market: Impact analysis 
3. Restraints of global blood glucose monitoring system market: Impact analysis
4. North America blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
5. North America blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
6. North America blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
7. North America blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
8. North America blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
9. North America blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
10. North America blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
11. The U.S. blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
12. The U.S. blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
13. The U.S. blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
14. The U.S. blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
15. The U.S. blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
16. The U.S. blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
17. The U.S. blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
18. Canada blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
19. Canada blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
20. Canada blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
21. Canada blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
22. Canada blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
23. Canada blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
24. Canada blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
25. Europe blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
26. Europe blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
27. Europe blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
28. Europe blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
29. Europe blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
30. Europe blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
31. Europe blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
32. UK blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
33. UK blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
34. UK blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
35. UK blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
36. UK blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
37. UK blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
38. UK blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
39. Germany blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
40. Germany blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
41. Germany blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
42. Germany blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
43. Germany blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
44. Germany blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
45. Germany blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
46. France blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
47. France blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
48. France blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
49. France blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
50. France blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
51. France blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
52. France blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
53. Rest of Europe blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
54. Rest of Europe blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
55. Rest of Europe blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
56. Rest of Europe blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
57. Rest of Europe blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
58. Rest of Europe blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
59. Rest of Europe blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
60. Asia Pacific blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
61. Asia Pacific blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
62. Asia Pacific blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
63. Asia Pacific blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
64. Asia Pacific blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
65. Asia Pacific blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
66. Asia Pacific blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
67. China blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
68. China blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
69. China blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
70. China blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
71. China blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
72. China blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
73. China blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
74. Japan blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
75. Japan blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
76. Japan blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
77. Japan blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
78. Japan blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
79. Japan blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
80. Japan blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
81. India blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
82. India blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
83. India blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
84. India blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
85. India blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
86. India blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
87. India blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
88. Rest of Asia Pacific blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
89. Rest of Asia Pacific blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
90. Rest of Asia Pacific blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
91. Rest of Asia Pacific blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
92. Rest of Asia Pacific blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
93. Rest of Asia Pacific blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
94. Rest of Asia Pacific blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
95. Latin America blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
96. Latin America blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
97. Latin America blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
98. Latin America blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
99. Latin America blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
100. Latin America blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
101. Latin America blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
102. Brazil blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
103. Brazil blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
104. Brazil blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
105. Brazil blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
106. Brazil blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
107. Brazil blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
108. Brazil blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
109. Rest of Latin America blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
110. Rest of Latin America blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
111. Rest of Latin America blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
112. Rest of Latin America blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
113. Rest of Latin America blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
114. Rest of Latin America blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
115. Rest of Latin America blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)
116. The Middle East & Africa blood glucose monitoring system market revenue, by product, 2015 – 2024 (USD Billion)
117. The Middle East & Africa blood glucose monitoring system market revenue, by self-monitoring, 2015 – 2024 (USD Billion)
118. The Middle East & Africa blood glucose monitoring system market revenue, by testing site, 2015 – 2024 (USD Billion)
119. The Middle East & Africa blood glucose monitoring system market revenue, by indication, 2015 – 2024 (USD Billion)
120. The Middle East & Africa blood glucose monitoring system market revenue, by type-I diabetes, 2015 – 2024 (USD Billion)
121. The Middle East & Africa blood glucose monitoring system market revenue, by type-II diabetes, 2015 – 2024 (USD Billion)
122. The Middle East & Africa blood glucose monitoring system market revenue, by end user, 2015 – 2024 (USD Billion)

Methodology

Free Analysis

Blood glucose monitoring devices are used to detect the glucose level in the blood. Glucose is a type of sugar present at a certain level in a human body. When this glucose level drops, a person suffers from diabetes. Blood glucose monitoring devices are used to monitor the glucose levels of diabetic patients.

The occurrence of diabetes is increasing at an exponential pace worldwide and has become one of the serious health concerns. WHO (World Health Organization) declared it a global epidemic due to its rapidly increasing prevalence. Approximately 30.3 million, i.e., 9.4% of the U.S. population is suffering from diabetes. The global incidence of diabetes has risen from 4.7% to 8.5%, i.e., doubled since the 1980s in adults. Increased prevalence of diabetes is mainly driving the growth of the blood glucose monitoring system market. Additionally, the increase in adoption of sugar surveillance system, increase in adoption of minimally invasive techniques, growing the aging population, technological advancements in the blood glucose monitoring systems, and rising awareness about the use of these systems in developing regions is anticipated to fuel the growth of the global blood glucose monitoring system market.  

Global Blood Glucose Monitoring System Market

The blood glucose monitoring system market is segmented on the basis of product type, testing site, indication, and end-user. Based on product type, the market for the blood glucose monitoring system is further segmented into self-monitoring devices and continuous glucose monitoring devices. Self-monitoring devices segment is further sub-segmented into blood glucose meters, lancets & lancets devices, and testing strips. The self-monitoring devices segment is dominating the global market for blood glucose monitoring system, owing to the rapid product development. On the basis of testing site, this market is further segmented into fingertip testing and alternate testing site. Fingertip testing is anticipated to dominate the market due to its accuracy. Based on the indication, the blood glucose monitoring system market is segmented into type-I diabetes, type-II diabetes, and gestational diabetes. Type-I and type-II diabetes are further sub-segmented into adult and pediatrics. Type-II diabetes segment is anticipated to dominate the application segment of blood glucose monitoring devices, due to the increase in the prevalence of this diabetes type. The end-user segment includes hospitals, clinics, and homecare. Homecare segment is anticipated to dominate the market.

North America is anticipated to dominate the market in the forecast period, due to rise in the initiatives undertaken by the government for prevention and treatment of diabetes with the help of leading players of the region, the rapid use of well-developed technology, and increase in R&D activities. The Asia Pacific is expected to show the highest growth due to an increase in the population suffering from diabetes. The increase in the aging population, lifestyle-associated changes, rising awareness regarding diabetes, and rapid urbanization are some of the factors fueling the growth of the blood glucose monitoring system market in the Asia Pacific region.

The key players operating in the global blood glucose monitoring system market are Abbott Laboratories, Novo Nordisk A/S, Hoffmann-La Roche Ltd., Sanofi, Medtronic, Nova Biomedical, B. Braun Melsungen, Terumo Corporation, ARKRAY Inc., and Becton, Dickinson, and Company. These companies focus on developing new technologies and getting it FDA approved so that they can launch it. For instance, in 2018, Medtronic received approval from FDA for smart continuous glucose monitor. In 2017, Abbott received approval from FDA for the first continuous glucose monitoring system that does not require blood sample calibration.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed